IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific & Clinical Advisors
    • Partnerships
  • The DPX Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • DPX-Survivac
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Careers
    • Overview
    • Life at IMV
  • Contact

Press Releases

News & Events

News & Events

  • Press Releases
  • Events
  • Email Alerts
Feb 02, 2010 6:00pm EST

Immunovaccine Hires Investor Relations Firm

Jan 28, 2010 6:00pm EST

Immunovaccine Grants Stock Options

Dec 09, 2009 8:45am EST

Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine

Nov 23, 2009 8:45am EST

Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health

Nov 10, 2009 8:45am EST

Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute

Nov 02, 2009 2:33pm EST

Immunovaccine Inc. Signs Cato Research Canada, Inc. as Clinical Trial CRO

Oct 29, 2009 9:10am EDT

Immunovaccine Expands Collaboration with Defence Research & Development Canada

Oct 22, 2009 4:22pm EDT

Immunovaccine Inc. Revises Escrow Securities Schedule

Oct 05, 2009 9:38am EDT

Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol "IMV"

RSS
  • Prev
  • 1...
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
IMV Inc.
About Us The DPX Platform Clinical Pipeline News & Events Investors Careers Contact
Twitter LinkedIn Youtube
© 2021 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap